Unknown

Dataset Information

0

18F-THK5351 PET Imaging in Nonfluent-Agrammatic Variant Primary Progressive Aphasia.


ABSTRACT: Background and Purpose:To analyze 18F-THK5351 positron emission tomography (PET) scans of patients with clinically diagnosed nonfluent/agrammatic variant primary progressive aphasia (navPPA). Methods:Thirty-one participants, including those with Alzheimer's disease (AD, n=13), navPPA (n=3), and those with normal control (NC, n=15) who completed 3 Tesla magnetic resonance imaging, 18F-THK5351 PET scans, and detailed neuropsychological tests, were included. Voxel-based and region of interest (ROI)-based analyses were performed to evaluate retention of 18F-THK5351 in navPPA patients. Results:In ROI-based analysis, patients with navPPA had higher levels of THK retention in the Broca's area, bilateral inferior frontal lobes, bilateral precentral gyri, and bilateral basal ganglia. Patients with navPPA showed higher levels of THK retention in bilateral frontal lobes (mainly left side) compared than NC in voxel-wise analysis. Conclusions:In our study, THK retention in navPPA patients was mainly distributed at the frontal region which was well correlated with functional-radiological distribution of navPPA. Our results suggest that tau PET imaging could be a supportive tool for diagnosis of navPPA in combination with a clinical history.

SUBMITTER: Yoon CW 

PROVIDER: S-EPMC6428011 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

<sup>18</sup>F-THK5351 PET Imaging in Nonfluent-Agrammatic Variant Primary Progressive Aphasia.

Yoon Cindy W CW   Jeong Hye Jin HJ   Seo Seongho S   Lee Sang-Yoon SY   Suh Mee Kyung MK   Heo Jae-Hyeok JH   Lee Yeong-Bae YB   Park Kee Hyung KH   Okamura Nobuyuki N   Lee Kyoung-Min KM   Noh Young Y  

Dementia and neurocognitive disorders 20180901 3


<h4>Background and purpose</h4>To analyze <sup>18</sup>F-THK5351 positron emission tomography (PET) scans of patients with clinically diagnosed nonfluent/agrammatic variant primary progressive aphasia (navPPA).<h4>Methods</h4>Thirty-one participants, including those with Alzheimer's disease (AD, <i>n</i>=13), navPPA (<i>n</i>=3), and those with normal control (NC, <i>n</i>=15) who completed 3 Tesla magnetic resonance imaging, <sup>18</sup>F-THK5351 PET scans, and detailed neuropsychological test  ...[more]

Similar Datasets

| S-EPMC6515576 | biostudies-literature
| S-EPMC3902758 | biostudies-literature
| S-EPMC5757514 | biostudies-literature
| S-EPMC6052568 | biostudies-literature
| S-EPMC6025736 | biostudies-literature
| S-EPMC3024013 | biostudies-other
| S-EPMC6425882 | biostudies-literature
| S-EPMC2931767 | biostudies-literature